Table 2.
Response rate to rituximab in patients with pemphigus vulgaris in groups A and B
| Group A | Group B | p-value | |||
|---|---|---|---|---|---|
| Response (%) | 37 (100) | 30 (79.0) | .006 | ||
| Complete remission (%) | 22 (59.4) | 15 (39.5) | .093 | ||
| Off therapy (%) | 3 (8.1) | 1 (2.6) | .295 | ||
| Minimal therapy (%) | 19 (51.4) | 14 (36.8) | .211 | ||
| Partial remission (%) | 15 (40.5) | 15 (39.4) | .923 | ||
| Off therapy (%) | 0 (0) | 2 (5.3) | .164 | ||
| Minimal therapy (%) | 6 (16.2) | 10 (26.3) | .293 | ||
| More than minimal therapy (%) | 9 (24.3) | 3 (7.9) | .060 | ||
| No response (%) | 0 (0) | 8 (21.0) | .006 | ||
| Relapse (%) | 0 (0) | 3 (7.9) | .090 | ||
| Persistent disease activity (%) | 0 (0) | 5 (13.2) | .028 | ||